Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia

Tyler A Berger,1 Matthew W Manry,1,2 Lucas B Lindsell,1,2 James M Osher,1,2 Daniel M Miller,1,2 Robert E Foster,1,2 Christopher D Riemann,1,2 Michael R Petersen,1,2 Robert A Sisk1– 3 1Department of Ophthalmology, University of Cincinnati, Cincinnati, OH, USA; 2Cincinnati Eye Institute, Cincinn...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Berger TA, Manry MW, Lindsell LB, Osher JM, Miller DM, Foster RE, Riemann CD, Petersen MR, Sisk RA
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Dove Medical Press 2021-03-01
סדרה:	Clinical Ophthalmology
נושאים:	antioxidant areds2 carotenoid supplementation ellipsoid zone loss lutein idiopathic macular telangiectasia macular telangiectasia juxtafoveal macular telangiectasia parafoveal telangiectasia retinal vascular disease.
גישה מקוונת:	https://www.dovepress.com/outcome-of-off-label-areds-2-supplementation-for-the-treatment-of-macu-peer-reviewed-article-OPTH
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!